HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oliver Liesenfeld Selected Research

Sulfadiazine (Sulphadiazine)

10/2018Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice.
2/2011SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood-brain barriers.
11/2007The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8-/- mice.
12/2004Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Oliver Liesenfeld Research Topics

Disease

30Infections
10/2022 - 07/2002
9Toxoplasmosis
10/2018 - 01/2003
8Sepsis (Septicemia)
10/2022 - 01/2010
8Inflammation (Inflammations)
01/2020 - 11/2004
5Ileitis
02/2015 - 12/2006
3COVID-19
03/2022 - 01/2020
3Virus Diseases (Viral Diseases)
12/2021 - 12/2020
3Encephalitis (Encephalitis, Rasmussen)
10/2014 - 12/2004
3Necrosis
01/2014 - 02/2002
3Colitis
07/2007 - 02/2003
2Coinfection
03/2022 - 10/2021
2Bacterial Infections (Bacterial Infection)
01/2022 - 10/2021
2Communicable Diseases (Infectious Diseases)
06/2021 - 12/2020
2Congenital Toxoplasmosis
10/2018 - 10/2014
2Spontaneous Abortion (Miscarriage)
12/2016 - 06/2016
2Diarrhea
12/2016 - 03/2007
2Hearing Loss (Hearing Impairment)
06/2016 - 02/2012
2Dizziness (Lightheadedness)
03/2016 - 04/2013
2Pneumonia (Pneumonitis)
01/2014 - 03/2007
2Hypersensitivity (Allergy)
02/2011 - 12/2004
2Parasitic Diseases (Parasitic Disease)
10/2008 - 08/2004
2Latent Infection
11/2007 - 12/2006
2Body Weight (Weight, Body)
03/2007 - 12/2004
2Parasitic Skin Diseases
08/2004 - 01/2004
2Helminthiasis (Helminthiases)
08/2004 - 01/2004
1Critical Illness (Critically Ill)
10/2021
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2020
1Nervous System Diseases (Neurological Disorders)
12/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2017
1Arthralgia (Joint Pain)
12/2016
1Obesity
12/2016
1Weight Gain
12/2016
1Lymphadenopathy
06/2016
1Heart Diseases (Heart Disease)
05/2016
1Shock
03/2016
1Low Back Pain (Lumbago)
03/2016
1Migraine Disorders (Migraine)
03/2016
1Mastodynia
03/2016
1Lung Neoplasms (Lung Cancer)
01/2016
1Ocular Toxoplasmosis
10/2014
1Pre-Eclampsia (Preeclampsia)
04/2014
1Eclampsia
04/2014
1HELLP Syndrome
04/2014
1Hemolysis
04/2014
1Syncope (Fainting)
04/2013
1Scabies (Sarcoptic Mange)
07/2012
1Pruritus (Itching)
07/2012
1Headache (Headaches)
02/2012
1Liver Diseases (Liver Disease)
05/2011

Drug/Important Bio-Agent (IBA)

14Immunoglobulin G (IgG)IBA
12/2017 - 03/2002
10AntibodiesIBA
05/2016 - 03/2002
10CytokinesIBA
02/2015 - 02/2003
7Messenger RNA (mRNA)IBA
10/2022 - 01/2020
6Immunoglobulin M (IgM)IBA
05/2016 - 03/2002
5Biomarkers (Surrogate Marker)IBA
10/2022 - 07/2007
5RNA (Ribonucleic Acid)IBA
03/2022 - 01/2021
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2007 - 02/2002
4ProcalcitoninIBA
01/2022 - 01/2020
4Anti-Bacterial Agents (Antibiotics)IBA
06/2021 - 12/2006
4Atovaquone (Mepron)FDA Link
10/2018 - 12/2004
4Sulfadiazine (Sulphadiazine)FDA Link
10/2018 - 12/2004
3Pyrimethamine (Daraprim)FDA Link
10/2018 - 12/2004
3EnzymesIBA
05/2016 - 05/2011
3Thomsen-Friedenreich antibodiesIBA
03/2016 - 02/2012
3Interleukin-22 (IL-22)IBA
02/2015 - 12/2009
3LigandsIBA
01/2013 - 11/2004
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 10/2021
2C-Reactive ProteinIBA
10/2021 - 06/2021
2Biological ProductsIBA
07/2021 - 03/2011
2Clindamycin (Cleocin)FDA LinkGeneric
10/2018 - 02/2011
2Interleukin-18 (Interleukin 18)IBA
02/2015 - 11/2004
2DNA (Deoxyribonucleic Acid)IBA
10/2014 - 01/2003
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2014 - 07/2007
2P-SelectinIBA
01/2013 - 12/2006
2Ivermectin (Mectizan)FDA Link
07/2012 - 08/2004
2Interleukin-12 (IL 12)IBA
12/2006 - 11/2004
1ClaudinsIBA
01/2022
1fluorescein isothiocyanate dextranIBA
01/2022
1GlucocorticoidsIBA
12/2020
1Thiamine (Aneurin)FDA Link
12/2020
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
12/2020
1SpiramycinIBA
10/2018
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
10/2018
1Azithromycin (Zithromax)FDA LinkGeneric
10/2018
1Clarithromycin (Biaxin)FDA LinkGeneric
10/2018
1Erlotinib Hydrochloride (CP 358,774)FDA Link
06/2017
1Pramipexole (Mirapex)FDA LinkGeneric
01/2017
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2014
1Bacterial DNAIBA
01/2014
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2011
1ChemokinesIBA
03/2011
1InterferonsIBA
01/2011

Therapy/Procedure

6Therapeutics
10/2018 - 12/2004
2Critical Care (Surgical Intensive Care)
12/2020 - 01/2020
2Drug Therapy (Chemotherapy)
06/2017 - 01/2004
2Aftercare (After-Treatment)
07/2012 - 03/2007
1Resuscitation
12/2020
1Stem Cell Transplantation
12/2017
1Cesarean Section (Caesarean Section)
12/2016
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2014